HUGHES ON HEADLINES “Public health shouldn’t be a secondary consideration for regulator”
It is pretty easy to view drug companies as Dr. Jekyll and Mr. Hyde type entities. For those who are relieved of symptoms or illness by proprietary drugs, they do good and important work. For tho…
